Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings

Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in commercial discussions

Read more at prnewswire.com